Form 8-K - Current report:
SEC Accession No. 0001193125-23-067912
Filing Date
2023-03-13
Accepted
2023-03-10 20:00:52
Documents
12
Period of Report
2023-03-10
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K d482844d8k.htm   iXBRL 8-K 21286
  Complete submission text file 0001193125-23-067912.txt   142776

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ubx-20230310.xsd EX-101.SCH 2868
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ubx-20230310_lab.xml EX-101.LAB 17978
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ubx-20230310_pre.xml EX-101.PRE 11271
6 EXTRACTED XBRL INSTANCE DOCUMENT d482844d8k_htm.xml XML 3357
Mailing Address 285 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 285 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 416-1192
Unity Biotechnology, Inc. (Filer) CIK: 0001463361 (see all company filings)

EIN.: 264726035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38470 | Film No.: 23725378
SIC: 2834 Pharmaceutical Preparations